Cargando…
Case Study – Germany
Public health structures in Germany reflect the federal system: health care in general lies within the responsibility of the 16 constituent states and the federal government only acts if a state asks for assistance. There were no bioterror-related intentional releases of biological agents in Germany...
Autores principales: | Uhlenhaut, Christine, Schaade, Lars, Finke, Ernst-Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121156/ http://dx.doi.org/10.1007/978-94-007-5273-3_10 |
Ejemplares similares
-
Contact Investigation for Imported Case of Middle East Respiratory Syndrome, Germany
por: Reuss, Annicka, et al.
Publicado: (2014) -
Lack of Evidence for Schmallenberg Virus Infection in Highly Exposed Persons, Germany, 2012
por: Ducomble, Tanja, et al.
Publicado: (2012) -
Letter to the editor: Wide indication for SARS-CoV-2-testing allowed identification of international risk areas during the early phase of the COVID-19 pandemic in Germany
por: Rexroth, Ute, et al.
Publicado: (2020) -
Estimating the share of SARS-CoV-2-immunologically naïve individuals in Germany up to June 2022
por: Maier, Benjamin F., et al.
Publicado: (2023) -
Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1–2016 – week 32–2020
por: Ullrich, Alexander, et al.
Publicado: (2021)